Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: Oncological features and biochemical properties

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 3, 2001, Pages 1104-1109

  Machens, Andreas ^a   Gimm, Oliver ^a   Hinze, Raoul ^a   Höppner, Wolfgang ^b   Boehm, Bernhard O ^c   Dralle, Henning ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYSTEINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CALCITONIN BLOOD LEVEL; CANCER RISK; CODON; EXON; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; THYROID MEDULLARY CARCINOMA;

ADOLESCENT; ADULT; AGED; CALCITONIN; CARCINOMA, MEDULLARY; CHILD; CHILD, PRESCHOOL; CODON; CYSTEINE; DROSOPHILA PROTEINS; EXONS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS;

EID: 0035048305     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.3.1104     Document Type: Article

References (30)

1. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A
2. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2
3. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma
4. Familial medullary thyroid carcinoma without associated endocrinopathies: A distinct entity
5. Mutations in the RET protooncogene are associated with MEN 2A and FMTC
6. Germline mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
7. Prophylactic surgery for multiple endocrine neoplasia type 2a after genetic diagnosis: Is parathyroid transplantation indicated?
8. Early presentation of metastatic medullary carcinoma in multiple endocrine neoplasia type IIA: Implications for therapy
9. Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience
10. Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma
11. Familial medullary thyroid carcinoma: Not a distinct entity? Genotype-phenotype correlation in a large family
12. Compartment oriented microdissection of regional lymph nodes in medullary thyroid carcinoma
13. Primary hereditary medullary thyroid carcinoma: C-cell morphology and correlation with preoperative calcitonin levels
14. A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A
15. The human protooncogene ret: A communicative cadherin?
16. cDNA cloning of mouse ret proto-oncogene and its sequence similarity to the cadherin superfamily
17. Signal transduction by receptors with tyrosine kinase activity
18. Activation of RET as a dominant transforming gene by germline mutations of MENA and MEN 2B
19. The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains
20. A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and a family with FMTC
21. RET mutations in exons 13 and 14 of FMTC patients
22. Update on the profile of multiple endocrine neoplasia type 2a RET mutations. Practical issues and implications for genetic testing
23. Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation
24. Biological properties of RET with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype
25. Medullary carcinoma in children. Results of early detection and surgery
26. Provocative testing for occult medullary carcinoma of the thyroid: Findings in seven children with multiple endocrine neoplasia type IIa
27. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B
28. Psychosocial impact of genetic testing in familial medullary thyroid carcinoma: A multicentric pilot-evaluation
29. Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG→ATG) mutation